Abstract:Human immunodeficiency virus (HIV)-specific cytotoxic T lymphocytes (CTL) are an important parameter of host defenses that limit viral replication after infection. Induction of effective CTL against conserved viral proteins such as Gag may be essential to the development of a safe and effective HIV type 1 (HIV-1) vaccine. DNA vaccination represents a novel strategy for inducing potent CD8(+) CTL responses in vivo. However, expression of HIV-1 structural proteins by DNA vectors has been hampered by a stringent requirement for coexpression with other viral components, such as Rev and RRE. Furthermore, even with Rev and RRE present, the level of expression of HIV-1 Gag, pol, or Env is very low in murine cells. These problems have limited our ability to address the key issue of how to generate effective CTL responses to Gag in a mouse model. To overcome this problem, we compared several novel DNA expression vectors for HIV-1 Gag protein expression in primate and mouse cells and for generating immune responses in mice after DNA vaccination. A DNA vector containing wild type HIV-1 gag coding sequences did not induce detectable Gag expression in any of the cells tested. Attempts to increase nuclear export of Gag expression RNA by adding the constitutive transport element yielded only a moderate increase in Gag expression in monkey-derived COS cells and an even lower increase in Gag expression in HeLa cells or several mouse cell lines. In contrast, silent-site mutations in the HIV-1 gag coding sequences significantly increased Gag expression levels in all cells tested. Furthermore, this construct induced both Gag-specific antibody and CTL responses in mice after DNA vaccination. Using this construct, we achieved stable expression of HIV-1 Gag in the mouse cell line p815, which can now be used as a target cell for measuring HIV-1 Gag-specific CTL responses in immunized mice. The DNA vectors described in this study should make it possible to systematically evaluate the approaches for maximizing the induction of CTL responses against HIV-1 Gag in mouse and other animal systems.

Construction and Immunogenicity of HIV-1 DNA Vaccine

Construction and Immunology of HIV-2 Gp105 and / or Gag DNA Vaccine

Construction and Immunological Study of Recombinant Plasmid with HIV-1 Gag and IFN - Alpha2b

[Construction and Identification of DNA Vaccine Containing Chimeric Gene Gag-Gp120 of HIV-1].

Evaluation Of Novel Human Immunodeficiency Virus Type 1 Gag Dna Vaccines For Protein Expression In Mammalian Cells And Induction Of Immune Responses

Construction and Immunogenicity of Recombinant Modified Vaccinia Ankara Expressing HIV-1 Gag-Pol Antigen

Construction and Vaccination of Recombinant HIV-1 DNA Vaccine for Therapeutic Use

Immunogenicity of DNA Vaccines Encoding Structural Proteins and Regulatory/accessory Proteins Derived from an HIV-1 CRF01_AE Isolate Circulating in China

Immunogenicities and comparison of DNA vaccines encoding pol genes derived from B｀/C and A/E recombinant HIV-1 strains

Construction of Replication-Deficient Recombinant Adenovirus Expressing Gag-Pola and Gp140tm Genes of Human Immunodeficiency Virus in Mice

Construction of HIV-1 Virus-like Particle Vaccine

Construction of a Recombinant HIV-1 Gp140 Protein Vaccine and Evaluation of Its Immunogenicity

Construction and Immunogenicity Analysis of a Vaccine Against HIV-1 AE Recombinant

Construction of Recombinant Fowlpox Virus(Rfpv) Expressing Hiv-1 Gag-Pol Protein

Enhancement of Primary and Secondary Cellular Immune Responses Against Human Immunodeficiency Virus Type 1 Gag by Using DNA Expression Vectors That Target Gag Antigen to the Secretory Pathway

[Immune Response Induced by HIV DNA Vaccine Combined with Recombinant Adeno-Associated Virus].

[Study on the Immunogenicity of HIV-1 Gag Vaccine].

Immunogenicity of a New DNA Vaccine Against HIV-1 B' Clade

[Construction of the Recombinant Lactococcus Lactis Expressing HIV-1 Gag Protein and Its Colonization in Mice].

[Construction of the DNA Vaccine of Major Outer Membrane Protein of Neisseria Gonorrhoeae and Investigation of Immune Effects after Vaccination].

Construction and Expression of DNA Vaccine Plasmid of HIV-1 Gp120 Gene Lfnalpha Gene